论文信息 - Benefit from Adjuvant TKIs Versus TKIs Plus Chemotherapy in EGFR-Mutant Stage III-pN2 Lung Adenocarcinoma - 字舞流文

Benefit from Adjuvant TKIs Versus TKIs Plus Chemotherapy in EGFR-Mutant Stage III-pN2 Lung Adenocarcinoma

W. Liang | Shuangbing Xu | Yi Zhao | Q. Pang | Junye Wang | H. Long | Qi-wen Li | Wanming Hu | J. Guo | Xin Wang | B. Qiu | N. Chen | Siyu Wang | Hui Liu | Songran Liu | M. Guo | Li Ma | Yu-ming Wen | Tian Zhang | Ling-juan Chen | Lingjuan Chen